[PDF][PDF] Systematic review and meta-analysis of the risk of major cardiovascular events with etoricoxib therapy
S Aldington, P Shirtcliffe, M Weatherall… - The New Zealand …, 2005 - Citeseer
S Aldington, P Shirtcliffe, M Weatherall, R Beasley
The New Zealand Medical Journal (Online), 2005•CiteseerTHE NEW ZEALAND M EDIC AL JO UR NAL Page 1 THE NEW ZEALAND M EDIC AL JO UR
NAL Vol 118 No 1223 ISSN 1175 8716 NZMJ 7 October 2005, Vol 118 No 1223 Page 1 of 6
URL: http://www.nzma.org.nz/journal/118-1223/1684/ © NZMA Systematic review and
meta-analysis of the risk of major cardiovascular events with etoricoxib therapy Sarah Aldington,
Philippa Shirtcliffe, Mark Weatherall, Richard Beasley Abstract Objective To determine the risk
of thromboembolic cardiovascular events associated with the use of etoricoxib, a COX-2 …
NAL Vol 118 No 1223 ISSN 1175 8716 NZMJ 7 October 2005, Vol 118 No 1223 Page 1 of 6
URL: http://www.nzma.org.nz/journal/118-1223/1684/ © NZMA Systematic review and
meta-analysis of the risk of major cardiovascular events with etoricoxib therapy Sarah Aldington,
Philippa Shirtcliffe, Mark Weatherall, Richard Beasley Abstract Objective To determine the risk
of thromboembolic cardiovascular events associated with the use of etoricoxib, a COX-2 …
Abstract
Objective To determine the risk of thromboembolic cardiovascular events associated with the use of etoricoxib, a COX-2 inhibitor.
Citeseer